Диссертация (Влияние синтетических ноотропных средств на активность металлозависимых протеиназ), страница 19

– 1995. – Vol. 45, N 6. – P.529 – 538.216. Silva, W.I. Neuropeptide like immunoreactivities and carboxypeptide Hactivity associated with bovine brain clathrin coated vesicles /W.I.Silva,K.Benitez, J.Ocasio, L.Martinez, N. Rosario // Neuropeptides. – 1995. – Vol.28, N 6. – P. 341 – 349.217. Skeggs, L.T. The preparatia and function of hypertensin converting enzyme/L.T.Skeggs, J.R.Jr.Kahn, N.P.Shumway // The Journal of experimentalmedicine. – 1956. – Vol. 103.

– P. 295.119218. Skidgel, R.A. Human carboxypeptidase N: lysine carboxypeptidase /R.A.Skidgel // Methods in enzymology. – 1995. – N 248. – 653 – 663.219. Skidgel, R.A. Structure and function of mammalian zinc carboxypeptidases.In Zinc Metalloproteases in Health and Disease /R.A. Skidgel// Taylor andFrancis Ltd, London, 1996. – P. 241 – 283220.

Skidgel, R.A., Erdös E.G. Structure and function of human plasmacarboxypeptidase N, the anaphylatoxin inactivator /R.A.Skidgel, E.G.Erdös //International immunopharmacology. – 2007. – N 7. – P. 1888 – 1899.221. Skidgel, R. A. Lysine carboxypeptidase.

In Handbook of ProteolyticEnzymes / R.A Skidgel, E.G.Erdös //Academic Press, London, 2004. – Vol. 1.– P. 837–840,222. Smith, D.R. Pituitary-specific transcriptional initiation sites of the ratcarboxypeptidase-H gene and the influence of thyroid hormone status/D.R.Smith, C.J.Pallen, D.Murphy, L.Lim // Molecular endocrinology. – 1992.– Vol. 6, N 5. – P. 713 – 722.223. Soffer, R.L. Angiotensin-converting enzyme: immunological, structural anddevelopmental aspects /R.L.Soffer, H.A. Ei-Dorry // Federation Proc.

– 1983. –P. 2735 – 2739224. Solnceva, E.I. The effect of piracetam and its novel peptide analogue GVS111 on neuronal voltage-gated calcium and potassium channels /E.I.Solnceva,J.V.Bukanova,R.U.Ostrovskaya,T.A.Gudasheva,T.A.Voronina,V.G.Skrebitsky // General pharmacology. – 1997. – Vol. 29. – P. 85 – 89.225. Song, L.X. Processing of procarboxypeptidase E into carboxypeptidase Eoccurs in secretory vesicles /L.X.Song, L.Fricker // Journal of neurochemistry.– 1995. – Vol. 65, N 1. – P.

444 – 453.226. Stone, T.E. Purification and Characterization of the Manduca SextaNeuropeptide Processing Enzyme Carboxypeptidase E /T.E.Stone, J.P.Li,P.Bernasconi // Archives of insect biochemistry and physiology. – 1994. – Vol.27, N 3. – P.

193 – 203.120227. Strittmatter, S.M. (3H)guanidinoethyl-mercaptosuccinic acid binding totissuehomogenates.Selectivelabelingofenkephalinconvertase/S.M.Strittmatter, D.R.Lynch, S.H.Snyder // The Journal of biologicalchemistry. – 1984. – Vol. 259, N 19. – P.

11812 – 11817.228. Supattapone, S. Purification and characterization of a membrane-boundenkephalin-formingcarboxypeptidase,"enkephalinconvertase"/S.Supattapone, L.D.Fricker, S.H.Snyder // Neurochemistry. – 1984. – Vol. 42,N 4. – P. 1017 – 1023.229. Tan, F. Protamine inhibits plasma carboxypeptidase N, the inactivator ofanaphylatoxins and kinins /F.Tan, H.Jackman, R.A.Skidgel, E.K.Zsigmond,E.G.Erdös // Anesthesiology. – 1989. – N 70. – P.

267 – 275.230. Tiurenkov, I.N. Comparative evalu- ation of the neuroprotective activity ofphenotropil and piracetam in laboratory animals with experimental cerebralischemia /I.N.Tiurenkov, M.N.Bagmetov, V.V.Epishina // Eksperimental'naia iklinicheskaia farmakologiia. – 2007. – N 70. – P. 24 – 29.231. Tschernitz, C. Biosynthesis of large dense core vesicles in PC12 cells:effects of depolarization and second messengers on the mRNA levels of theirconstituets /C.Tschernitz, A.Laslop, C.Eiter, S.Kroesen, H.Winkler // Brainresearch. Molecular brain research.

– 1995. – Vol. 31, N 1-2. – P. 131 – 140.232. Wallace, E.F. Carboxypeptidase B activity from adrenal medulla - is itinvolved in the processing of proenkephalin? /E.F.Wallace, C.J.Evans,S.M.Jurik, I.N.Mettord, J.D.Barchas // Life sciences. – 1982. – Vol. 31, N 16–17. – P. 1793 – 1796.233. Winblad, B. Piracetam: a review of pharmacological properties and clinicaluses / B.Winblad // CNS Drug Reviews. – 2005. – Vol. 11, N 2. – P.

169 –182.234. Windisch, M. Cognition-enhancing (Nootropic) drugs /M. Windisch // BrainMechanisms and Psychotropic Drugs. CRC Press, 1996. – P. 239-257.121235. Winnicka, K. Piracetam - an old drug with novel properties? /K. Winnicka,M. Tomasiak, A.Bielawska // Acta poloniae pharmaceutica. – 2005. N 62. – P.405 –409.236. Yajima, R. A rapid anterograde axonal transport of carboxypeptidase H inrat sciatic nerves /R.Yajima, T.Chikuma, T.Kato // Journal of neurochemistry.– 1994. – Vol. 63, N 3. – P.

997 – 1002.237. Zavadenko, N.N. Sequelae of closed craniocerebral trauma and the efficacyof piracetam in its treatment in adolescents /N.N.Zavadenko, L.S. Guzilova //Neuroscience and Behavioral Physiology. – 2009. – Vol. 39, N 4. – P. 323 –328.238. Zheng, M. The developmental expression in rat of proteases furin, Pc1, Pc2,and carboxypeptidase E - implications for early maturation of proteolyticprocessingcapacity/M.Zheng,R.D.Streck,R.E.M.Scott,N.G.Seidah,J.E.Pintar // The Journal of neuroscience: the official journal of the Society forNeuroscience. – 1994.

– Vol. 14, N 8. – P. 4656 – 4673.239. Zvejniece, L. Investigation into stereoselective pharmacological activity ofphenotropil /L.Zvejniece, B.Svalbe, G.Veinberg, S.Grinberga, M.Vorona,I.Kalvinsh, M.Dambrova // Basic & Clinical Pharmacology & Toxicology,Nordic Pharmacological Society. – 2011. – Vol. 109, N 5. – P. 407 – 412.122Приложение.